Physician profile
Eric Chau
NPI 1568944668
$3,441.80
in general payments reported to CMS, 2019-2025
20 companies · $2,357 in 2025
The $2,357 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,085 · 2025: $2,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,441.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $922.35 | 2024-2025 | |
| Amgen INC. | $553.37 | 2024-2025 | Evenity, Otezla, Prolia |
| Ucb, INC. | $296.44 | 2024-2025 | Bimzelx, Cimzia |
| Gilead Sciences, INC. | $256.53 | 2024-2025 | Vemlidy |
| Radius Health, INC. | $221.52 | 2024-2025 | Tymlos |
| Aurinia Pharma U.S., INC. | $211.05 | 2024-2025 | Lupkynis |
| Glaxosmithkline, LLC. | $174.37 | 2025 | Benlysta |
| Astrazeneca Pharmaceuticals Lp | $168.39 | 2024-2025 | Saphnelo |
| Pfizer INC. | $139.90 | 2024-2025 | |
| Celltrion USA INC. | $78.04 | 2024-2025 | Vegzelma |
| Ani Pharmaceuticals, INC. | $65.09 | 2024-2025 | Purified Cortrophin Gel |
| Fresenius Kabi USA, LLC | $58.49 | 2024 | Tyenne, Idacio |
| Alexion Pharmaceuticals, INC. | $57.14 | 2024-2025 | Strensiq |
| E.R. Squibb & Sons, L.L.C. | $47.37 | 2025 | Orencia |
| Sobi, INC | $46.59 | 2024-2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $34.42 | 2025 | Actemra |
| Kiniksa Pharmaceuticals International, Plc | $29.98 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $28.69 | 2025 | |
| Mallinckrodt Hospital Products INC. | $27.26 | 2025 | Acthar |
| Ultragenyx Pharmaceutical INC. | $24.81 | 2024 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.